Walleye Capital
IONS icon

Walleye Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Walleye Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254K Buy
3,200
+1,700
+113% +$128K ﹤0.01% 3315
2026
Q1 		$113K Sell
1,500
-9,400
-86% -$742K ﹤0.01% 3624
2025
Q4 		$862K Buy
10,900
+5,400
+98% +$407K ﹤0.01% 2562
2025
Q3 		$360K Buy
5,500
+1,100
+25% +$53.7K ﹤0.01% 2863
2025
Q2 		$174K Sell
4,400
-11,100
-72% -$363K ﹤0.01% 3465
2025
Q1 		$468K Sell
15,500
-13,000
-46% -$426K ﹤0.01% 2624
2024
Q4 		$996K Buy
28,500
+22,100
+345% +$826K ﹤0.01% 2397
2024
Q3 		$256K Sell
6,400
-31,200
-83% -$1.45M ﹤0.01% 3826
2024
Q2 		$1.79M Buy
37,600
+34,300
+1,039% +$1.41M ﹤0.01% 2215
2024
Q1 		$143K Sell
3,300
-5,300
-62% -$253K ﹤0.01% 4181
2023
Q4 		$435K Sell
8,600
-13,000
-60% -$623K ﹤0.01% 3060
2023
Q3 		$980K Sell
21,600
-8,100
-27% -$334K ﹤0.01% 2268
2023
Q2 		$1.22M Buy
29,700
+9,800
+49% +$377K ﹤0.01% 1687
2023
Q1 		$711K Buy
+19,900
New +$747K 0.01% 1406
2020
Q1 		– Sell
-100
Closed -$6K – 1283
2019
Q4 		$6K Sell
100
-800
-89% -$47.7K ﹤0.01% 1671
2019
Q3 		$54K Sell
900
-2,100
-70% -$137K ﹤0.01% 1587
2019
Q2 		$193K Buy
3,000
+2,400
+400% +$170K 0.02% 984
2019
Q1 		$49K Buy
+600
New +$38.7K 0.01% 1212

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Walleye Capital's IONS Position: Q2 2026 in Review

Walleye Capital reduced its Ionis Pharmaceuticals (IONS) stake by 100% in Q2 2026, selling an estimated $4.96M and leaving 2 shares worth $159. The position accounts for ﹤0.01% of the portfolio, ranked #4635.

Walleye Capital first reported a position in IONS in Q1 2019 and has held it in 16 quarters since. The position peaked at $4.97M in Q3 2024. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Walleye Capital held 2 shares of Ionis Pharmaceuticals worth $159 as of Q2 2026.
  • Walleye Capital sold 65,947 Ionis Pharmaceuticals shares in Q2 2026, an estimated $4.96M.
  • Ionis Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4635 holding.
  • Walleye Capital first reported a position in Ionis Pharmaceuticals in Q1 2019 and has held it in 16 quarters since.
  • Walleye Capital's Ionis Pharmaceuticals position peaked at $4.97M in Q3 2024.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.